Ruscus aculeatus, extract
CAS 84012-38-4
Ruscus aculeatus, extract (CAS 84012-38-4) is a pharmaceutical compound with 0 bioactivity targets and 22 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Ruscus aculeatus, extract is linked to DTXSID301036483 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ruscus aculeatus, extract used for in pharmaceutical contexts?
Ruscus aculeatus, extract (CAS 84012-38-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ruscus aculeatus, extract?
Ruscus aculeatus, extract has 22 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Anal pruritus, Anxiety, Chronic kidney disease-associated pruritus, Drug interaction, Impaired work ability. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ruscus aculeatus, extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ruscus Aculeatus Root Extract with EU status "permitted".
What clinical phase is Ruscus aculeatus, extract in?
No phase 1-4 clinical development badge is rendered for Ruscus aculeatus, extract because the matched compound identifier rows do not contain a max-phase value.